ES413501A1 - Alpha-amino-rho-hydroxyphenylacetamidocephalosporins - Google Patents

Alpha-amino-rho-hydroxyphenylacetamidocephalosporins

Info

Publication number
ES413501A1
ES413501A1 ES413501A ES413501A ES413501A1 ES 413501 A1 ES413501 A1 ES 413501A1 ES 413501 A ES413501 A ES 413501A ES 413501 A ES413501 A ES 413501A ES 413501 A1 ES413501 A1 ES 413501A1
Authority
ES
Spain
Prior art keywords
formula
amino
hydroxyphenylacetamidocephalosporins
ococh3
acylating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES413501A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES413501A1 publication Critical patent/ES413501A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A procedure for preparing α-amino-p-hydroxyphenylacetamidocephalosporins of the formula **(See formula)** wherein R is 5-methyl-1,3,4-thiadiazol-2-yl or 1-methyl-5-tetrazolyl, comprising: (1) acylating an aminocephalosporin compound of the formula **(See formula)** wherein X is S-R, where R is as defined above, or OCOCH3, with α-amino-p-hydroxyphenylacetic acid or with an acylating or activated derivative thereof, with the OH or NH2 groups being adequately protected as required; (2) when X is OCOCH3, react the resulting compound with a heterocyclic thioalcohol of the formula HS-R, where R is as defined above, and (3) remove any possible protecting groups. (Machine-translation by Google Translate, not legally binding)
ES413501A 1972-06-14 1973-04-09 Alpha-amino-rho-hydroxyphenylacetamidocephalosporins Expired ES413501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins

Publications (1)

Publication Number Publication Date
ES413501A1 true ES413501A1 (en) 1976-07-16

Family

ID=26949532

Family Applications (2)

Application Number Title Priority Date Filing Date
ES412207A Expired ES412207A1 (en) 1972-06-14 1973-03-01 Alpha-amino-rho-hydroxyphenylacetamidocephalosporins
ES413501A Expired ES413501A1 (en) 1972-06-14 1973-04-09 Alpha-amino-rho-hydroxyphenylacetamidocephalosporins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES412207A Expired ES412207A1 (en) 1972-06-14 1973-03-01 Alpha-amino-rho-hydroxyphenylacetamidocephalosporins

Country Status (20)

Country Link
JP (2) JPS5518716B2 (en)
AR (1) AR197237A1 (en)
AT (1) AT324560B (en)
AU (1) AU464107B2 (en)
CA (2) CA1076560A (en)
CH (2) CH586709A5 (en)
DD (1) DD105238A5 (en)
DE (1) DE2316867C2 (en)
DK (1) DK142913B (en)
ES (2) ES412207A1 (en)
FI (1) FI56843C (en)
FR (2) FR2187298B1 (en)
GB (2) GB1363833A (en)
HU (1) HU168689B (en)
IE (2) IE37409B1 (en)
IL (1) IL42126A (en)
NL (2) NL7302817A (en)
PH (1) PH9941A (en)
PL (1) PL91074B1 (en)
SE (2) SE416472B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR780000197B1 (en) * 1972-12-26 1978-05-26 Bristol Myers Co Method for preparing antibacterial agent
JPS5953275B2 (en) * 1973-01-31 1984-12-24 ブリストル マイヤ−ズ カンパニ− Antibacterial agent manufacturing method
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
NL162387C (en) * 1977-09-06 1980-05-16 Gist Brocades Nv PROCESS FOR PREPARING 6- (D-ALPHA-AMINO-P- HYDROXYPHENYLACETAMIDO) PENICILLANIC ACID.
JPS6010226U (en) * 1983-06-30 1985-01-24 松下電工株式会社 lift device
JPS6182606A (en) * 1984-09-29 1986-04-26 東芝ライテック株式会社 Lift

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA698494B (en) * 1969-02-26 1971-07-28 Lilly Co Eli Sulfur-containing cephalosporing antibiotics
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
FI56843C (en) 1980-04-10
DD105238A5 (en) 1974-04-12
DE2316866A1 (en) 1974-01-03
ES412207A1 (en) 1976-01-01
IE37409B1 (en) 1977-07-20
CH589093A5 (en) 1977-06-30
DE2316867A1 (en) 1974-01-03
AT324560B (en) 1975-09-10
SE404190B (en) 1978-09-25
FR2187298A1 (en) 1974-01-18
IE37499B1 (en) 1977-08-03
DE2316866B2 (en) 1976-10-07
PL91074B1 (en) 1977-02-28
IE37409L (en) 1973-12-14
NL7305206A (en) 1973-12-18
DE2316867C2 (en) 1982-05-19
JPS4954393A (en) 1974-05-27
AU5234573A (en) 1974-08-22
IE37499L (en) 1973-12-14
IL42126A0 (en) 1973-06-29
FR2187299B1 (en) 1976-12-03
CA999293A (en) 1976-11-02
JPS5953274B2 (en) 1984-12-24
DK142913B (en) 1981-02-23
FR2187298B1 (en) 1976-12-03
CH586709A5 (en) 1977-04-15
JPS5518716B2 (en) 1980-05-21
CA1076560A (en) 1980-04-29
HU168689B (en) 1976-06-28
GB1358027A (en) 1974-06-26
JPS4931689A (en) 1974-03-22
AU464107B2 (en) 1975-08-14
AR197237A1 (en) 1974-03-22
FI56843B (en) 1979-12-31
FR2187299A1 (en) 1974-01-18
SE416472B (en) 1981-01-05
GB1363833A (en) 1974-08-21
NL7302817A (en) 1973-12-18
PH9941A (en) 1976-06-14
DK142913C (en) 1981-09-28
IL42126A (en) 1975-12-31

Similar Documents

Publication Publication Date Title
ES413501A1 (en) Alpha-amino-rho-hydroxyphenylacetamidocephalosporins
ES420412A1 (en) Piperidinesulfonylurea derivatives
ES329449A1 (en) A procedure for the preparation of penicillins. (Machine-translation by Google Translate, not legally binding)
ES317685A1 (en) A procedure for preparing 1- (p-acetyphenyl) -2- (2,2-dichloroacetamido) -1,3-propanodiol. (Machine-translation by Google Translate, not legally binding)
ES402674A1 (en) Antibacterial agents and a process for the preparation thereof
ES324901A1 (en) A procedure for the preparation of derivatives of 2,6-diclorotiobenzamida. (Machine-translation by Google Translate, not legally binding)
ES282993A1 (en) Procedure for the optical clarification of organic materials (Machine-translation by Google Translate, not legally binding)
ES314496A1 (en) Procedure for the preparation of tiazolinic heterociclic derivatives. (Machine-translation by Google Translate, not legally binding)
ES324454A1 (en) A procedure for the preparation of penicillins. (Machine-translation by Google Translate, not legally binding)
ES419813A1 (en) A procedure for the preparation of new derivatives of penama and cefama. (Machine-translation by Google Translate, not legally binding)
JPS51133277A (en) A process for preparing novel carbostyril derivatives
ES444483A1 (en) A procedure for the preparation of new derivatives of acid2,3-alquilen (lower) penam-3-carboxylic. (Machine-translation by Google Translate, not legally binding)
ES302771A1 (en) Procedure for the production of heterocyclic compounds (Machine-translation by Google Translate, not legally binding)
ES458846A1 (en) A procedure for the preparation of new cephalosporins. (Machine-translation by Google Translate, not legally binding)
ES401829A1 (en) Certain dithio-carbamate derivatives of 5-hydroxymethyl-picolinic acid
JPS5283829A (en) Cyclic compound
ES374393A1 (en) Phenylbutazone-sodium-monoglycerate
ES426124A1 (en) Procedure for the preparation of new derivatives of cefalosporanic acid. (Machine-translation by Google Translate, not legally binding)
ES406806A3 (en) Procedure for the obtaining of polyurethane prepolimeros solutions. (Machine-translation by Google Translate, not legally binding)
ES391071A1 (en) Carbamoyloxy-quinoline derivatives
ES362645A2 (en) A procedure for the preparation of penicillins. (Machine-translation by Google Translate, not legally binding)
ES382147A1 (en) A procedure for preparing N-substituted morpholine compounds. (Machine-translation by Google Translate, not legally binding)
JPS5283677A (en) Derivative of 2-(7-indenyloxymethyl)-4-substituted morpholine
ES464682A3 (en) A procedure for the protection of wood and wood products. (Machine-translation by Google Translate, not legally binding)
ES362824A1 (en) Procedure for obtaining antiulcerosous compounds. (Machine-translation by Google Translate, not legally binding)